{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:06:07Z","timestamp":1792058767578,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Acquired hypothalamic obesity is a complex condition resulting from hypothalamic damage, often due to tumors. However, not all children with hypothalamic masses develop obesity; while hypothalamic involvement is a recognised factor, the impact of specific surgical approaches and concurrent endocrine deficits on diverse tumour cohorts requires further elucidation. To evaluate clinical, radiological, surgical, and endocrine factors associated with obesity in children with hypothalamic tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included 34 pediatric patients with hypothalamic tumors (median age at diagnosis: 6.0 years; IQR: 6) followed between 1999 and 2020. Patients with conditions or medications causing obesity were excluded. Data on tumor characteristics, treatment modalities, surgical approach, and endocrine abnormalities were collected. Obesity was defined as BMI &gt; +2 SDS, and patients were grouped as obese and non-obese for comparative analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The most frequent tumor types were optic glioma, pilocytic astrocytoma, and craniopharyngioma. Obesity developed in 15 patients (44.1%). The median time to obesity onset was 3.00 months (IQR: 12.50) after diagnosis, with no significant difference in total follow-up duration between obese and non-obese groups (3.00 vs 3.50 years, p=0.471). At diagnosis, the groups differed significantly regarding surgical history, particularly pterional craniotomy (p=0.048), and the presence of adrenal insufficiency (p=0.020) or hypogonadism (p=0.004). However, univariable logistic regression showed that surgical method was not significantly associated with obesity. Obesity was also significantly associated with insulin resistance (p=0.010) and dyslipidemia (p=0.019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, hypothalamic obesity develops rapidly in children with hypothalamic tumors, often within the first few months following diagnosis. While surgical intervention\u2014particularly via pterional craniotomy\u2014showed a significant association with obesity in bivariate analysis, this association was not statistically significant in univariable logistic regression. The presence of obesity is closely linked to metabolic disturbances such as insulin resistance and dyslipidemia, as well as adrenal insufficiency and hypogonadism. These findings emphasize the necessity of early metabolic screening and personalized follow-up strategies immediately after diagnosis for this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-026-04665-w","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:53:31Z","timestamp":1779987211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with acquired hypothalamic obesity in children with hypothalamic tumors: a comparative single-center study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-0727","authenticated-orcid":false,"given":"Fulya","family":"METE KALAYCI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-4404","authenticated-orcid":false,"given":"Deniz","family":"\u00d6ZALP KIZILAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-5814","authenticated-orcid":false,"given":"Eda","family":"ATASEVEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-4321","authenticated-orcid":false,"given":"Mehmet","family":"KANTAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-976X","authenticated-orcid":false,"given":"Ulu\u00e7","family":"\u00d6ZKIZILTAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-762X","authenticated-orcid":false,"given":"Elif","family":"BOLAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-9901","authenticated-orcid":false,"given":"Asl\u0131","family":"SUNER KARAK\u00dcLAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-0591","authenticated-orcid":false,"given":"Damla","family":"G\u00d6K\u015eEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-6397","authenticated-orcid":false,"given":"\u015e\u00fckran","family":"DARCAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7037-2713","authenticated-orcid":false,"given":"Samim","family":"\u00d6ZEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"10","key":"4665_CR1","doi-asserted-by":"publisher","first-page":"e230147","DOI":"10.1530\/EC-23-0147","volume":"12","author":"IMAA van Roessel","year":"2023","unstructured":"van I.M.A.A. Roessel, de J.P. Graaf, N.R. Biermasz, E. Charmandari, van H.M. Santen, Acquired hypothalamic dysfunction in childhood: what do patients need? \u2013 an Endo-ERN survey. Endocr. Connect. 12(10), e230147 (2023). https:\/\/doi.org\/10.1530\/EC-23-0147","journal-title":"Endocr. Connect."},{"key":"4665_CR2","doi-asserted-by":"publisher","first-page":"846880","DOI":"10.3389\/fendo.2022.846880","volume":"13","author":"P Dimitri","year":"2022","unstructured":"P. Dimitri, Treatment of acquired hypothalamic obesity: Now and the future. Front. Endocrinol. (Lausanne). 13, 846880 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.846880","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4665_CR3","doi-asserted-by":"publisher","unstructured":"J. Argente, I.S. Farooqi, J.A. Chowen, P. K\u00fchnen, M. L\u00f3pez, E. Morselli et al., Hypothalamic obesity: from basic mechanisms to clinical perspectives. Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00283-3. https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3","DOI":"10.1016\/S2213-8587(24)00283-3"},{"key":"4665_CR4","doi-asserted-by":"publisher","first-page":"1256514","DOI":"10.3389\/fendo.2023.1256514","volume":"14","author":"CL Roth","year":"2023","unstructured":"C.L. Roth, A. Zenno, Treatment of hypothalamic obesity in people with hypothalamic injury: New drugs are on the horizon. Front. Endocrinol. (Lausanne). 14, 1256514 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1256514","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"4665_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/clinem\/dgad057","volume":"108","author":"AH Shoemaker","year":"2023","unstructured":"A.H. Shoemaker, J. Tamaroff, Approach to the patient with hypothalamic obesity. J. Clin. Endocrinol. Metab. 108(5), 1236\u20131242 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad057","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4665_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/er.2018-00163","volume":"40","author":"L van Iersel","year":"2019","unstructured":"van L. Iersel, K.E. Brokke, R.A.H. Adan, L.C.M. Bulthuis, van den E.L.T. Akker, van H.M. Santen, Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: A systematic review. Endocr. Rev. 40(1), 193\u2013235 (2019). https:\/\/doi.org\/10.1210\/er.2018-00163","journal-title":"Endocr. Rev."},{"issue":"2","key":"4665_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000499945","volume":"91","author":"MJ Abuzzahab","year":"2019","unstructured":"M.J. Abuzzahab, C.L. Roth, A.H. Shoemaker, Hypothalamic obesity: Prologue and promise. Horm. Res. Paediatr. 91(2), 128\u2013136 (2019). https:\/\/doi.org\/10.1159\/000499945","journal-title":"Horm. Res. Paediatr."},{"key":"4665_CR8","doi-asserted-by":"publisher","unstructured":"H.L. M\u00fcller, Current Approaches and Therapeutic Strategies for Hypothalamic Syndrome in Patients with Childhood-onset Craniopharyngioma. J. Clin. Res. Pediatr. Endocrinol. 2026 Jan 15  https:\/\/doi.org\/10.4274\/jcrpe.galenos.2025.2025-12-12","DOI":"10.4274\/jcrpe.galenos.2025.2025-12-12"},{"key":"4665_CR9","doi-asserted-by":"crossref","unstructured":"H.L. M\u00fcller, T. Tanaka, T. Hasegawa, T. Isojima, J. Mori, M. Kurosaki, H. Nishioka, H.J. Choi, A.R. Hong, J.H. Kim, H. Arima, Diagnostic criteria for acquired hypothalamic obesity - international expert guidance document. Endocr. J. 2025 Nov 11","DOI":"10.1507\/endocrj.EJ25-0408"},{"issue":"2","key":"4665_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00701-020-04598-8","volume":"163","author":"S Sarkar","year":"2021","unstructured":"S. Sarkar, S.R. Chacko, S. Korula, A. Simon, S. Mathai, G. Chacko et al., Long-term outcomes following maximal safe resection in a contemporary series of childhood craniopharyngiomas. Acta Neurochir. (Wien). 163(2), 499\u2013509 (2021). https:\/\/doi.org\/10.1007\/s00701-020-04598-8","journal-title":"Acta Neurochir. (Wien)"},{"issue":"2","key":"4665_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00381-020-04961-3","volume":"37","author":"MA Fouda","year":"2021","unstructured":"M.A. Fouda, D. Zurakowski, R.M. Scott, K.J. Marcus, P.E. Manley, N.J. Ullrich et al., Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma. Childs Nerv. Syst. 37(2), 403\u2013410 (2021). https:\/\/doi.org\/10.1007\/s00381-020-04961-3","journal-title":"Childs Nerv. Syst."},{"key":"4665_CR12","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1016\/j.wneu.2022.09.025","volume":"167","author":"Z Huang","year":"2022","unstructured":"Z. Huang, J. Wu, J. Qi, C. Pan, J. Fu, T. Hong, Risk factors associated with postoperative obesity in childhood-onset craniopharyngioma patients: A case-control study. World Neurosurg. 167, e1185\u2013e1195 (2022). https:\/\/doi.org\/10.1016\/j.wneu.2022.09.025","journal-title":"World Neurosurg."},{"issue":"4","key":"4665_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4274\/jcrpe.2183","volume":"7","author":"O Neyzi","year":"2015","unstructured":"O. Neyzi, R. Bundak, G. G\u00f6k\u00e7ay, H. G\u00fcn\u00f6z, A. Furman, F. Darendeliler et al., Reference values for weight, height, head circumference, and body mass index in Turkish children. J. Clin. Res. Pediatr. Endocrinol. 7(4), 280\u2013293 (2015). https:\/\/doi.org\/10.4274\/jcrpe.2183","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4665_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/TCRM.S285878","volume":"18","author":"D Nistic\u00f2","year":"2022","unstructured":"D. Nistic\u00f2, B. Bossini, S. Benvenuto, M.C. Pellegrin, G. Tornese, Pediatric adrenal insufficiency: Challenges and solutions. Ther. Clin. Risk Manag. 18, 47\u201360 (2022). https:\/\/doi.org\/10.2147\/TCRM.S285878","journal-title":"Ther. Clin. Risk Manag"},{"issue":"11","key":"4665_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1042\/CS20230062","volume":"137","author":"K Koysombat","year":"2023","unstructured":"K. Koysombat, W.S. Dhillo, A. Abbara, Assessing hypothalamic pituitary gonadal function in reproductive disorders. Clin. Sci. (Lond). 137(11), 863\u2013879 (2023). https:\/\/doi.org\/10.1042\/CS20230062","journal-title":"Clin. Sci. (Lond)"},{"key":"4665_CR16","doi-asserted-by":"crossref","unstructured":"Z. \u015e\u0131klar, E. \u00d6zsu, S. K\u0131z\u0131lcan \u00c7etin, S. \u00d6zen, F. \u00c7izmecio\u011flu-Jones, H.G. Balk\u0131, Z. Aycan, D. G\u00f6k\u015fen, F. Kilci, S.N. Abseyi, U. Tercan, G. G\u00fcrp\u0131nar, \u015e. Poyrazo\u011flu, F. Darendeliler, K. Demir, \u00d6. Besci, \u0130.T. \u00d6zgen, S.B. Ak\u0131n, Z. Kocabey S\u00fct\u00e7\u00fc, E.H. Ayka\u00e7 Kaplan, E. \u00c7amtosun, \u0130. D\u00fcndar, E. Sa\u011fsak, H.A. Korkmaz, A. An\u0131k, G. Ye\u015filtepe Mutlu, B. \u00d6zcabi, U\u00e7ar A, Da\u011fdeviren \u00c7ak\u0131r A, Selver Eklio\u011flu B, B. K\u0131rel, M. Berbero\u011flu, Comprehensive Insights Into Pediatric Craniopharyngioma: Endocrine and Metabolic Profiles, Treatment Challenges, and Long-term Outcomes from a Multicenter Study. J Clin Res Pediatr Endocrinol. 2024;16(3):288\u2013296","DOI":"10.4274\/jcrpe.galenos.2024.2024-1-3"},{"issue":"12","key":"4665_CR17","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/neuonc\/noad112","volume":"25","author":"J Van Schaik","year":"2023","unstructured":"Van J. Schaik, A.Y.N. Schouten-van Meeteren, E. Vos-Kerkhof, G.O. Janssens, G.L. Porro, M. Fiocco, B. Bakker, W.J.E. Tissing, E.W. Hoving, van H.M. Santen, Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study: First results after centralization of care. Neuro Oncol. 25(12), 2250\u20132261 (2023)","journal-title":"Neuro Oncol."},{"issue":"3","key":"4665_CR18","doi-asserted-by":"publisher","first-page":"lvad027","DOI":"10.1093\/ejendo\/lvad027","volume":"188","author":"J Beckhaus","year":"2023","unstructured":"J. Beckhaus, C. Friedrich, S. Boekhoff, G. Calaminus, B. Bison, M. Eveslage, B. Timmermann, J. Flitsch, H.L. M\u00fcller, Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage. Eur. J. Endocrinol. 188(3), lvad027 (2023)","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"4665_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/oby.21096","volume":"23","author":"CL Roth","year":"2015","unstructured":"C.L. Roth, H. Eslamy, D. Werny, C. Elfers, M.L. Shaffer, C. Pihoker et al., Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obes. (Silver Spring). 23(6), 1226\u20131233 (2015). https:\/\/doi.org\/10.1002\/oby.21096","journal-title":"Obes. (Silver Spring)"},{"issue":"9\u201310","key":"4665_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1159\/000505780","volume":"110","author":"EM Erfurth","year":"2020","unstructured":"E.M. Erfurth, Diagnosis, background, and treatment of hypothalamic damage in craniopharyngioma. Neuroendocrinology. 110(9\u201310), 767\u2013779 (2020). https:\/\/doi.org\/10.1159\/000505780","journal-title":"Neuroendocrinology"},{"issue":"11","key":"4665_CR21","first-page":"1617","volume":"9","author":"F Claude","year":"2022","unstructured":"F. Claude, G. Ubertini, G. Szinnai, Endocrine Disorders in Children with Brain Tumors: At Diagnosis, after Surgery, Radiotherapy and Chemotherapy. Child. (Basel). 9(11), 1617 (2022)","journal-title":"Child. (Basel)"},{"issue":"3","key":"4665_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2016-2573","volume":"102","author":"DM Styne","year":"2017","unstructured":"D.M. Styne, S.A. Arslanian, E.L. Connor, I.S. Farooqi, M.H. Murad, J.H. Silverstein et al., Pediatric obesity\u2014Assessment, treatment, and prevention: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 102(3), 709\u2013757 (2017). https:\/\/doi.org\/10.1210\/jc.2016-2573","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4665_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-8587(24)00101-3","volume":"12","author":"CL Roth","year":"2024","unstructured":"C.L. Roth, C. Scimia, A.H. Shoemaker, M. Gottschalk, J. Miller, G. Yuan et al., Setmelanotide for the treatment of acquired hypothalamic obesity: A phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol. 12(6), 380\u2013389 (2024). https:\/\/doi.org\/10.1016\/S2213-8587(24)00101-3","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04665-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:53:34Z","timestamp":1779987214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4665"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04665-w","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Ege University Faculty of Medicine Clinical Research Ethics Committee, \u0130zmir, T\u00fcrkiye, approval number 24-12.1T\/59 (date: December 26, 2024). Because this was a retrospective chart review study, the requirement for written informed consent was waived by the same Ethics Committee in accordance with institutional and national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This research complies with the guidelines for human studies and is conducted ethically following the World Medical Association Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements"}}],"article-number":"193"}}